This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board approves unaudited results for quarter ended 30 September 2026; no figures given
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The filing provides no consolidated figures for the quarter ended 30 September 2026, so a comparison with the same quarter a year earlier is not possible. The board met on 4 November 2026 and approved unaudited financial results, a statement of assets and liabilities, a cash flow statement and a limited review report issued by the statutory auditor.
Investors cannot assess earnings, margins, cash flow or debt trends from this filing because no financial figures are disclosed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹44.37 Cr | ₹34.64 Cr | +28.1% |
| Operating profit | ₹17.31 Cr | ₹14.66 Cr | +18.1% |
| Profit after tax | ₹13.59 Cr | ₹11.08 Cr | +22.7% |
| EBITDA margin | 41.3% | 44.7% | −3.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.